Mutant human immunodeficiency virus type 1 genomes with defects in RNA dimerization or encapsidation.
about
Global changes in the RNA binding specificity of HIV-1 gag regulate virion genesisIdentification of a minimal region of the HIV-1 5'-leader required for RNA dimerization, NC binding, and packagingStructural determinants and mechanism of HIV-1 genome packagingIs HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably?A new NMR solution structure of the SL1 HIV-1Lai loop-loop dimerA retroviral RNA kissing complex containing only two G{middle dot}C base pairsCation-dependent cleavage of the duplex form of the subtype-B HIV-1 RNA dimerization initiation siteThe Life-Cycle of the HIV-1 Gag-RNA ComplexEvolutionary analysis of human immunodeficiency virus type 1 therapies based on conditionally replicating vectorsSequences in the 5' and 3' R elements of human immunodeficiency virus type 1 critical for efficient reverse transcriptionAn intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA.Infectious molecular clones with the nonhomologous dimer initiation sequences found in different subtypes of human immunodeficiency virus type 1 can recombine and initiate a spreading infection in vitro.Elucidation and characterization of oligonucleotide-accessible sites on HIV-2 leader region RNA.A genomic selection strategy to identify accessible and dimerization blocking targets in the 5'-UTR of HIV-1 RNARev proteins of human and simian immunodeficiency virus enhance RNA encapsidation.Studies of the genomic RNA of leukosis viruses: implications for RNA dimerization.Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes.High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.HIV-1 DIS stem loop forms an obligatory bent kissing intermediate in the dimerization pathway.A heterologous, high-affinity RNA ligand for human immunodeficiency virus Gag protein has RNA packaging activityThe human immunodeficiency virus type 1 TAR RNA upper stem-loop plays distinct roles in reverse transcription and RNA packaging.Contributions of viral splice sites and cis-regulatory elements to lentivirus vector function.Mutations within four distinct gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site.An intact U5-leader stem is important for efficient replication of simian immunodeficiency virus.Novel, live attenuated simian immunodeficiency virus constructs containing major deletions in leader RNA sequencesBinding characteristics of small molecules that mimic nucleocapsid protein-induced maturation of stem-loop 1 of HIV-1 RNA.Mutations in matrix and SP1 repair the packaging specificity of a Human Immunodeficiency Virus Type 1 mutant by reducing the association of Gag with spliced viral RNAEffects of a single amino acid substitution within the p2 region of human immunodeficiency virus type 1 on packaging of spliced viral RNAHuman immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots.Dimerization of HIV-1 genomic RNA of subtypes A and B: RNA loop structure and magnesium bindingThe leader of the HIV-1 RNA genome forms a compactly folded tertiary structureTwo alternating structures of the HIV-1 leader RNASequences within both the 5' UTR and Gag are required for optimal in vivo packaging and propagation of mouse mammary tumor virus (MMTV) genomic RNAThe determination of importance of sequences neighboring the Psi sequence in lentiviral vector transduction and packaging efficiency.Effects of mutations in the human immunodeficiency virus type 1 Gag gene on RNA packaging and recombinationHIV-1 RNA dimerization: It takes two to tangoMapping the RNA binding sites for human immunodeficiency virus type-1 gag and NC proteins within the complete HIV-1 and -2 untranslated leader regions.The dimer initiation sequence stem-loop of human immunodeficiency virus type 1 is dispensable for viral replication in peripheral blood mononuclear cells.Strong epistatic selection on the RNA secondary structure of HIVRole of HIV-1 RNA and protein determinants for the selective packaging of spliced and unspliced viral RNA and host U6 and 7SL RNA in virus particles
P2860
Q24498694-668FCF05-172D-4EE9-A71B-2556DC368412Q24622200-7FE0DEED-8B58-4C3C-9F30-3D169CA86EB3Q24632055-F74998B5-59CC-4226-9828-F22FE2AAE056Q24805927-354CD270-60A2-4645-BB86-874D7441BF4CQ25255880-5BDC0273-ECC7-474A-BE2B-1D9EA3169E45Q27626111-6AC29900-1FE5-4B56-9DE0-0A60F633CB29Q27661496-916BAC5A-33F8-42E6-98A4-90D34F23C56BQ28076985-0C08763A-DEA2-4847-AFCD-52771E1413B2Q28484825-45A18A64-9D1A-4522-B346-4EF7A04FE817Q28646669-5CDCAB48-66F1-472C-B79F-3F3731FB7C01Q30303886-45DFE502-9842-4A26-B43A-71A68D45CC99Q30430249-2DCB6AA7-701A-4555-83F6-7D6183D9E6FDQ30915689-7BD0815F-4239-4B64-BA14-F37FF649E815Q33202244-131DA77D-64A7-468B-AB17-2AD0CB74F08BQ33282047-2848E343-0BA8-472D-B96B-B8DAD2747EF6Q33648835-23482332-5092-4608-9D2A-07E7EE00C61AQ33755180-BF597AE9-23E2-44B2-ACF2-DCD59A9DDC5DQ33785302-BF30EEDE-44AE-4712-A0AC-64C627E75484Q33791142-D30B559F-9A36-4E2E-A744-AE019F787A1CQ33795610-15AAD988-C0CF-41D6-8856-3985B8D5D11CQ33805882-58046DBD-4C46-4570-AD13-94EAE3DA6AADQ33816167-70D9DC16-F613-41F1-868F-A6B1495A729DQ33818125-88751211-DF1C-465E-9D5E-67512556D626Q33850342-31DA4B6E-8D47-4DA5-9BF7-1CA882EF4502Q33865700-252A0C45-D86A-4C7E-B86B-70CF6AB66BF7Q34066427-FCA7AB2C-4465-4A09-87FC-C9B7CFFE58E7Q34138829-026857F0-A167-4D06-8E25-9906F60262C7Q34226913-CF29043B-AB66-42E8-845A-DD54D4C7EBA2Q34355430-C7C89E92-9711-4A20-A8D3-A638FC9E6CC9Q34362112-84A0D1C2-8FDE-4293-9976-308C4922A8D9Q34362436-B6AD2FC2-8577-4832-889E-6C46271F14AEQ34363290-D953EAFD-7194-4DE3-B7BC-5B41BA07892DQ34450549-0A2C01CF-6BB7-488E-B9CF-829870ACE5C5Q34491104-41EB2C1F-64F9-47A3-9439-2B7EA66C0A3DQ34647902-D474CACF-CABC-434F-9C1A-D9DCC121441DQ34666010-CBB4CA9E-0F57-4470-879E-A6406B052CCAQ34673247-65134C8B-102C-4BB4-94AB-B0CE4D76971CQ35155279-94550595-4975-447A-98FD-9FD17CFCE970Q35247429-B97EC7E3-8234-49E3-9294-06D2D7F72838Q35468374-8542A322-5464-45EF-921B-1FF608B50CBB
P2860
Mutant human immunodeficiency virus type 1 genomes with defects in RNA dimerization or encapsidation.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Mutant human immunodeficiency ...... dimerization or encapsidation.
@en
Mutant human immunodeficiency ...... dimerization or encapsidation.
@nl
type
label
Mutant human immunodeficiency ...... dimerization or encapsidation.
@en
Mutant human immunodeficiency ...... dimerization or encapsidation.
@nl
prefLabel
Mutant human immunodeficiency ...... dimerization or encapsidation.
@en
Mutant human immunodeficiency ...... dimerization or encapsidation.
@nl
P2860
P1433
P1476
Mutant human immunodeficiency ...... dimerization or encapsidation.
@en
P2093
J L Clever
T G Parslow
P2860
P304
P407
P577
1997-05-01T00:00:00Z